08/18/2025
The Texas Cardiac Arrhythmia Institute (TCAI) at St. David’s Medical Center is the first in the country to implant a newly FDA-approved leadless device that delivers cardiac resynchronization therapy to patients with heart failure.
The device, about the size of a grain of rice is implanted directly into the heart’s left ventricle and uses ultrasound energy to restore normal rhythm and improve heart function. Cardiac resynchronization therapy improves the timing of the heart’s contractions, helping to restore the normal rhythm of the heartbeat.
Unlike traditional systems that rely on wired leads, this wireless approach allows more precise placement and expands treatment options for patients who were previously considered untreatable.
TCAI continues to lead in innovative heart care with advanced, minimally invasive therapies. Thank you to the team pictured below for their dedication and innovation!
To read more about this first of its kind treatment: https://bit.ly/46WOK0x
To learn more about TCAI visit: https://bit.ly/4mOQEFg